Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05208892 · ClinicalTrials.gov registry record · NA
Dexmedetomidine Use in SZMN Blocks for Pediatric T&A Pain Control
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 114
- Enrollment target
NCT05208892: Completed NA study, sponsored by Stanford University.
NCT05208892 is a NA study that has completed, run by Stanford University. The registered enrollment target is 114 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05208892, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
Study Summary
The suprazygomatic maxillary nerve (SZMN) block is a well-established, safe and effective regional technique for pain management following cleft palate procedures. However, it has not been studied for patients undergoing tonsillectomy and adenoidectomy (T\&A) procedures. The goal of this study is to determine whether the SZMN block can be utilized to improve pain control and decrease morbidity in pediatric patients undergoing T\&A. An additional goal will be to determine whether the use of dexmedetomidine as a local anesthetic adjunct can prolong the analgesic effects of the SZMN block to cover the entire duration of pain experienced.
Interventions
- PROCEDURE SZMN block
- PROCEDURE SZMN block with Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2024-01-29 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05208892
The ClinicalTrials.gov registry entry for NCT05208892 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SZMN block is the first listed.
NCT05208892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05208892 about?
NCT05208892 is a clinical study titled "Dexmedetomidine Use in SZMN Blocks for Pediatric T&A Pain Control". The suprazygomatic maxillary nerve (SZMN) block is a well-established, safe and effective regional technique for pain management following cleft palate procedures. However, it has not been studied for patients undergoing tonsillectomy and adenoidectomy (T\&A) procedures. The goal of this study is to...
What is the current status of trial NCT05208892?
This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2024-01-29. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT05208892?
The interventions under investigation include: SZMN block (PROCEDURE), SZMN block with Dexmedetomidine (PROCEDURE).
Who is sponsoring clinical trial NCT05208892?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.